Light Mode
$3.75 ↑ +0.05 (+1.35%) Trading Up from the previous close of $3.70
-1.52 (-29.12%) / 6M
Momentum, market sentiment, and recent alerts
IRD reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +72.9%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.